In addition, the immunophenotypic findings of PD-L1 expression in tumor cells and intratumoral inflammatory cells have proven relevant as a method of evaluation to establish an independent prognostic factor in several solid and hematologic tumors and even in some as a favorable indicator of immune therapy response. Here, CD274 is linked to hematopoietic and lymphoid cell neoplasm.